Literature DB >> 11993540

Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies.

S Rüegg, M Stahl, M Bühlmann, A Dupont, P A Lyrer, R L Humbel, A J Steck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11993540     DOI： 10.1007/s004150200019

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

Review 1.  The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid.

Authors:  L M Levy; M C Dalakas; M K Floeter
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

2.  Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.

Authors:  J Peltola; P Kulmala; J Isojärvi; A Saiz; K Latvala; J Palmio; K Savola; M Knip; T Keränen; F Graus
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

3.  Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.

Authors:  T Lohmann; M Hawa; R D Leslie; R Lane; J Picard; M Londei
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

4.  Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.

Authors:  H Takenoshita; M Shizuka-Ikeda; H Mitoma; S Song; Y Harigaya; Y Igeta; M Yaguchi; K Ishida; M Shoji; M Tanaka; H Mizusawa; K Okamoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

5.  Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia.

Authors:  B Giometto; D Miotto; F Faresin; V Argentiero; T Scaravilli; B Tavolato
Journal:  J Neurol Sci       Date:  1996-11       Impact factor: 3.181

6.  Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

Authors:  J Honnorat; A Saiz; B Giometto; A Vincent; L Brieva; C de Andres; J Maestre; N Fabien; A Vighetto; R Casamitjana; C Thivolet; B Tavolato; J Antoine; P Trouillas; F Graus
Journal:  Arch Neurol       Date:  2001-02

7.  Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.

Authors:  A Saiz; J Arpa; A Sagasta; R Casamitjana; J J Zarranz; E Tolosa; F Graus
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

8.  Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.

Authors:  K Dinkel; H M Meinck; K M Jury; W Karges; W Richter
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

9.  Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.

Authors:  K Daw; N Ujihara; M Atkinson; A C Powers
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

10.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

Authors:  J Tuomilehto; P Zimmet; I R Mackay; P Koskela; G Vidgren; L Toivanen; E Tuomilehto-Wolf; K Kohtamäki; J Stengård; M J Rowley
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321
View more
  2 in total

Review 1.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

Review 2.  Guidelines for treatment of immune-mediated cerebellar ataxias.

Authors:  Hiroshi Mitoma; Marios Hadjivassiliou; Jérôme Honnorat
Journal:  Cerebellum Ataxias       Date:  2015-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.